A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.
Wirth LJ, Krane JF, Li Y, Othus M, Moran AE, Dorfman DM, Norris CM Jr, Goguen L, Posner MR, Haddad RI, Bertagnolli MM.
Wirth LJ, et al. Among authors: goguen l.
Cancer Prev Res (Phila). 2008 Oct;1(5):339-48. doi: 10.1158/1940-6207.CAPR-07-0003.
Cancer Prev Res (Phila). 2008.
PMID: 19138978
Clinical Trial.